Antimetabolite/Antineoplastic Agent-- Drugs of this class prevent the growth of abnormal cells and tissues.
Methotrexate is a medication associated with chemotherapy that works against folic acid. It inhibits the enzyme dihydrofolate reductase, that converts folic acid to tetrahydrofolic acid. This causes interference with DNA replication and cell reproduction. Methotrexate is used to treat cancers and lesions associated with psoriasis. It also has been shown to have immunosuppressive qualities and thus has been used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
| Condition | Information | Oral Dosage |
Rheumatoid arthritis |
Severe; for active RA with insufficient response to first line therapy |
7.5 mg once weekly or |
Wegener’s granulomatosis |
|
5-20 mg/week |
You should not take this medication if you are allergic to methotrexate. You should also not take this medication if you are pregnant or breastfeeding. Patients who have experienced alcoholism, chronic liver disease, preexisting blood abnormailities or immunodeficiency syndromes, should NOT take this medication, unless directed to do so after consultation with their physician.
| Drug Name | Interaction |
Aspirin, cyclosporine (Gengraf®, Neoral®, sandimmmune®), sulfa antibiotics, penicillins |
Increases methotrexate toxicity secondary to reduced excretion by the kidneys. |
Ibuprofen (Motrin®), Naproxen (Alleve®, Naprosyn®) |
Increases methotrexate toxicity. |
Azathioprine (Imuran®), sulfasalazineAzulfidine®) |
Increases the risk of liver toxicity. |
Steroids |
May reduce efficacy of methotrexate |
Vaccines: |
May increase the risk of infection secondary to vaccines derived from live viruses |